Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
Journal of Genetics and Genomics = Yi Chuan Xue Bao|August 6, 2021
Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibilityMiriam Zuccalà, Nadia Barizzone, Elena Boggio, et al.Journal of Neurology|November 3, 2023
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster doseMassimiliano Di Filippo, Diana Ferraro, Paolo Ragonese, et al.Journal of Neurology|March 18, 2018
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT studyRoberta Lanzillo, Luca Prosperini, Claudio Gasperini, et al.Multiple Sclerosis and Related Disorders|November 4, 2019
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre studyDiana Ferraro, Pietro Annovazzi, Marcello Moccia, et al.Journal of Neurology|February 15, 2022
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective studyAntonio Riccardo Buonomo, Giulio Viceconte, Massimiliano Calabrese, et al.Neurology|December 16, 2022
Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter StudySara Carta, Álvaro Cobo Calvo, Thaís Armangué, et al.Journal of Neurology|October 25, 2017
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter studySara Mariotto, Sergio Ferrari, Salvatore Monaco, et al.Journal of Neurology|February 17, 2024
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT)Alessia Bianchi, Domenica Matranga, Francesco Patti, et al.Plos One|August 2, 2017
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)Silvia Messina, Claudio Solaro, Isabella Righini, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 15, 2020
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre studyClara Grazia Chisari, Claudio Solaro, Pasquale Annunziata, et al.Pageof 9